NO20003601L - Nye naftyl-substituerte og anilid-substituerte sulfonamider - Google Patents

Nye naftyl-substituerte og anilid-substituerte sulfonamider

Info

Publication number
NO20003601L
NO20003601L NO20003601A NO20003601A NO20003601L NO 20003601 L NO20003601 L NO 20003601L NO 20003601 A NO20003601 A NO 20003601A NO 20003601 A NO20003601 A NO 20003601A NO 20003601 L NO20003601 L NO 20003601L
Authority
NO
Norway
Prior art keywords
substituted
anilide
sulfonamides
naphthyl
new
Prior art date
Application number
NO20003601A
Other languages
English (en)
Other versions
NO20003601D0 (no
Inventor
Wolfgang Bender
Juergen Reefschloger
Peter Eckenberg
Siegfried Goldmann
Michael Horter
Sabine Hallenberger
Joerg Trappe
Olaf Weber
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20003601D0 publication Critical patent/NO20003601D0/no
Publication of NO20003601L publication Critical patent/NO20003601L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår nye naftyl- og anilid-substituerte sulfonamider med den generelle formel (I), hvori substituentene A, D, E, G, R, R, R, Rog X har de angitte betydningene, samt fremgangsmåte for deres fremstilling og deres anvendelse som antivirale midler, spesielt mot cytomegalievirus.
NO20003601A 1998-01-23 2000-07-13 Nye naftyl-substituerte og anilid-substituerte sulfonamider NO20003601L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802439 1998-01-23
PCT/EP1999/000099 WO1999037609A1 (de) 1998-01-23 1999-01-09 Neue naphthyl- und anilid-substituierte sulfonamide

Publications (2)

Publication Number Publication Date
NO20003601D0 NO20003601D0 (no) 2000-07-13
NO20003601L true NO20003601L (no) 2000-09-14

Family

ID=7855411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003601A NO20003601L (no) 1998-01-23 2000-07-13 Nye naftyl-substituerte og anilid-substituerte sulfonamider

Country Status (30)

Country Link
US (1) US6417181B1 (no)
EP (1) EP1049666B1 (no)
JP (1) JP2002501043A (no)
KR (1) KR20010034321A (no)
CN (1) CN1294578A (no)
AR (1) AR016978A1 (no)
AT (1) ATE242207T1 (no)
AU (1) AU2420799A (no)
BG (1) BG104617A (no)
BR (1) BR9907738A (no)
CA (1) CA2318182A1 (no)
CO (1) CO4810231A1 (no)
DE (1) DE59905829D1 (no)
EE (1) EE200000432A (no)
ES (1) ES2201666T3 (no)
GT (1) GT199900010A (no)
HR (1) HRP20000532A2 (no)
HU (1) HUP0200918A2 (no)
ID (1) ID25448A (no)
IL (1) IL137159A0 (no)
NO (1) NO20003601L (no)
NZ (1) NZ505900A (no)
PE (1) PE20000181A1 (no)
PL (1) PL341815A1 (no)
SK (1) SK11012000A3 (no)
SV (1) SV1999000006A (no)
TR (1) TR200002140T2 (no)
TW (1) TW461880B (no)
WO (1) WO1999037609A1 (no)
ZA (1) ZA99473B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (de) 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19934321A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Naphthyl-substituierte Sulfonamide
DE19934295A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid
JP4448902B2 (ja) * 2001-06-08 2010-04-14 株式会社医薬分子設計研究所 スルホンアミド誘導体
AU2003231370A1 (en) * 2002-04-18 2003-10-27 Institute Of Medicinal Molecular Design. Inc. Amide derivatives
US7491827B2 (en) 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
US7378525B2 (en) * 2002-12-23 2008-05-27 Millennium Pharmaceuticals, Inc. CCR8 inhibitors
TW200510311A (en) 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
US7425527B2 (en) * 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
RU2452490C1 (ru) 2010-12-27 2012-06-10 Виктор Вениаминович Тец Лекарственное средство с активностью против семейства герпес-вирусов
EP2846788A1 (en) 2012-05-11 2015-03-18 Akron Molecules AG Use of compounds for the treatment of pain
RU2530587C1 (ru) 2013-06-07 2014-10-10 Виктор Вениаминович Тец Способ лечения заболеваний кожи и слизистых оболочек, вызываемых вирусами простого герпеса 1-го и 2-го типов
RU2605602C1 (ru) * 2015-09-15 2016-12-27 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения натриевой соли (2,6-дихлорфенил)амида карбопентоксисульфаниловой кислоты
CN112062901B (zh) * 2020-08-14 2023-03-21 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2423572A (en) * 1946-05-03 1947-07-08 Du Pont Naphtholsulfonamidobenzaldehydes and acetals thereof
US2949479A (en) * 1954-06-17 1960-08-16 Dainippon Pharmaceutical Co Acyl derivatives of aminonaphthalene-sulfonamide
US3925347A (en) 1967-07-24 1975-12-09 Polaroid Corp Processes of synthesizing azo compounds
US3482971A (en) 1967-07-24 1969-12-09 Polaroid Corp Scavengers for oxidized developing agent
US4035401A (en) 1970-03-30 1977-07-12 Polaroid Corporation Intermediates for photographic dyes
JPS5499433A (en) 1978-01-20 1979-08-06 Konishiroku Photo Ind Co Ltd Dye image formation method
EP0284130B1 (en) 1987-03-19 1991-06-26 Agfa-Gevaert N.V. Organic compounds for use in a dye diffusion transfer process and photographic elements incorporating them
AU5175490A (en) * 1989-02-27 1990-09-26 Du Pont Merck Pharmaceutical Company, The Novel sulfonamides as radiosensitizers
DE4331134A1 (de) 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame Pseudopeptide
EP0684515A1 (en) 1994-05-27 1995-11-29 Eastman Kodak Company Photographic element and process incorporating a high dye-yield image coupler providing improved granularity

Also Published As

Publication number Publication date
HRP20000532A2 (en) 2001-02-28
US6417181B1 (en) 2002-07-09
EP1049666B1 (de) 2003-06-04
KR20010034321A (ko) 2001-04-25
BR9907738A (pt) 2000-10-17
AR016978A1 (es) 2001-08-01
TW461880B (en) 2001-11-01
JP2002501043A (ja) 2002-01-15
CO4810231A1 (es) 1999-06-30
CA2318182A1 (en) 1999-07-29
DE59905829D1 (de) 2003-07-10
NO20003601D0 (no) 2000-07-13
AU2420799A (en) 1999-08-09
PE20000181A1 (es) 2000-04-12
EP1049666A1 (de) 2000-11-08
WO1999037609A1 (de) 1999-07-29
ATE242207T1 (de) 2003-06-15
ES2201666T3 (es) 2004-03-16
HUP0200918A2 (en) 2002-09-28
EE200000432A (et) 2001-12-17
CN1294578A (zh) 2001-05-09
NZ505900A (en) 2002-02-01
IL137159A0 (en) 2001-07-24
PL341815A1 (en) 2001-05-07
ZA99473B (en) 1999-07-27
SV1999000006A (es) 2000-10-09
GT199900010A (es) 2000-07-15
SK11012000A3 (sk) 2001-01-18
TR200002140T2 (tr) 2000-12-21
BG104617A (en) 2001-04-30
ID25448A (id) 2000-10-05

Similar Documents

Publication Publication Date Title
NO992821L (no) Ketobenzamider som calpain-inhibitorer
NO20006251L (no) Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO950533D0 (no) Hydroksyetylaminosulfonamider som er nyttige som retrovirale proteasehemmere
NO20063028L (no) 6-substituerte 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
NO20050199L (no) Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet
NO940550L (no)
DE60313472D1 (de) Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren
NO20005264L (no) Heterocyklisk substituerte amider, deres fremstilling og anvendelse
DE69919397D1 (de) Thrombin-inhibitoren
NO974744L (no) Oksygenert-heterocykelinneholdende sulfonamidhemmere av aspartylprotease
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
DK1064273T3 (da) 1,3,4-Thiadiazoler, som er nyttige til behandling af CMV-infektioner
NO971538L (no) Purin- og guaninforbindelser som inhibitorer for PNP
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
NO20021503L (no) Kinazolinoner
IL158324A0 (en) Arylsulphonamides as anttiviral agents
TR200200100T2 (tr) Kristalin 1-metilkarbapenem türevleri.
TR200001452T2 (tr) Bifenilamidin türevleri.
NO20012914D0 (no) Nye amidinoderivater og deres anvendelse som trombininhibitorer
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
BR9813719A (pt) Agentes terapêuticos
FI955498A0 (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application